€58.36
2.46% day before yesterday
Paris, Jun 06, 05:35 pm CET
ISIN
FR0014000MR3
Symbol
ERF

Eurofins Scientific Stock price

€58.36
+1.16 2.03% 1M
+11.25 23.88% 6M
+9.05 18.35% YTD
+3.56 6.50% 1Y
+0.20 0.34% 5Y
+31.50 117.23% 10Y
+55.77 2,153.28% 20Y
Paris, Closing price Fri, Jun 06 2025
+1.40 2.46%
ISIN
FR0014000MR3
Symbol
ERF
Sector

Key metrics

Market capitalization €10.38b
Enterprise Value €13.37b
P/E (TTM) P/E ratio 32.07
EV/FCF (TTM) EV/FCF 16.92
EV/Sales (TTM) EV/Sales 1.92
P/S ratio (TTM) P/S ratio 1.49
P/B ratio (TTM) P/B ratio 2.04
Dividend yield 1.03%
Last dividend (FY24) €0.60
Revenue growth (TTM) Revenue growth 6.70%
Revenue (TTM) Revenue €6.95b
EBIT (operating result TTM) EBIT €1.04b
Free Cash Flow (TTM) Free Cash Flow €790.50m
Cash position €613.90m
EPS (TTM) EPS €1.82
P/E forward 21.60
P/S forward 1.40
EV/Sales forward 1.80
Show more

Is Eurofins Scientific a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,823 stocks worldwide.

Eurofins Scientific Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Eurofins Scientific forecast:

5x Buy
33%
7x Hold
47%
3x Sell
20%

Analyst Opinions

15 Analysts have issued a Eurofins Scientific forecast:

Buy
33%
Hold
47%
Sell
20%

Financial data from Eurofins Scientific

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
6,951 6,951
7% 7%
100%
- Direct Costs 5,399 5,399
5% 5%
78%
1,552 1,552
14% 14%
22%
- Selling and Administrative Expenses 138 138
-
2%
- Research and Development Expense - -
-
-
1,576 1,576
16% 16%
23%
- Depreciation and Amortization 535 535
3% 3%
8%
EBIT (Operating Income) EBIT 1,041 1,041
24% 24%
15%
Net Profit 353 353
38% 38%
5%

In millions EUR.

Don't miss a Thing! We will send you all news about Eurofins Scientific directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Eurofins Scientific SE engages in the bio-analytical testing of food, environment, and pharmaceuticals products. The firm offers testing and laboratory services for agro science, genomics, discovery pharmacology and for supporting clinical studies. It operates through the following geographical segments: Europe, North America, and Rest of the World. The company was founded by Gilles G. Martin in 1987 and is headquartered in Luxembourg.

Head office France
CEO Gilles Martin
Employees 62,696
Founded 2012
Website www.eurofins.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today